ACCESSION: MSBNK-SMB_Measured-HSA001P0167009
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'15_posi_15245': {'bp': 240579.0, 'sum': 341079.0}, '19_posi_15076': {'bp': 239926.0, 'sum': 341038.0}, '19_posi_14992': {'bp': 230086.0, 'sum': 328540.0}, '19_posi_14907': {'bp': 209661.0, 'sum': 301160.0}, '19_posi_15245': {'bp': 206831.0, 'sum': 308128.0}, '19_posi_15159': {'bp': 184191.0, 'sum': 238036.0}, '18_posi_15056': {'bp': 174335.0, 'sum': 271062.0}, '10_posi_15056': {'bp': 169591.0, 'sum': 267655.0}, '8_posi_15056': {'bp': 167993.0, 'sum': 275836.0}, '19_posi_14825': {'bp': 167191.0, 'sum': 240106.0}, '9_posi_14825': {'bp': 159806.0, 'sum': 261270.0}, '14_posi_15034': {'bp': 156569.0, 'sum': 245850.0}, '18_posi_14802': {'bp': 140347.0, 'sum': 215433.0}}
COMMENT: RETENTION_TIME_STDEV 0.298
COMMENT: PRECURSOR_M/Z_RAW 167.128718
COMMENT: PRECURSOR_M/Z_STDEV 0.000069
COMMENT: PRECURSOR_IN_MS1 mz 167.129050; int 53.603; delta(ppm) 1.308147
COMMENT: PROPOSED_CHARGE_STATE +1; mz 168.132336; int 4.257; cor 0.800
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 126.102532; int 348.492; cor 0.813
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 126.102532; int 348.492; cor 0.813
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 126.102532; int 348.492; cor 0.813
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.439; C8H14N4; [M+H]+; delta(ppm) -0.439437
COMMENT: PROPOSED_MF SevenGoldenRules 0.568; C6H11N3; [M+ACN+H]+; delta(ppm) -0.567568
COMMENT: PROPOSED_MF MS-FINDER 4.111; C6H11N3; [M+ACN+H]+; delta(ppm) 98769.515818
COMMENT: PROPOSED_MF MS-FINDER 4.019; C8H14N4; [M+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.033; C4H8N2; [M+C4H6N2+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.033; C8H14N4; [M+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS5_Sirius -4.341; C10H16NO; [M+H]+; delta(ppm) -8.475844
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H8N2; [M+C4H6N2+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4; [M+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.423; C4H8N2; [M+C4H6N2+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.423; C6H11N3; [M+C2H3N+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.423; C8H14N4; [M+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.147; C6H15O; [M+C2H3N+Na]+; delta(ppm) 56833.228998
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.731; C5H15FN4O; [M+H]+; delta(ppm) -7.279124
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.148; C8H13O; [M+C2H3N+H]+; delta(ppm) -8.475844
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.148; C10H16NO; [M+H]+; delta(ppm) -8.475844
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.929; C4H17N5P; [M+H]+; delta(ppm) -2.291704
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2; [M+C4H6N2+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H15O; [M+C2H3N+Na]+; delta(ppm) 56833.228998
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3; [M+C2H3N+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4; [M+H]+; delta(ppm) -0.442222
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.076; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; N#CCCNCCNCCC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.649; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+ACN+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.336; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+ACN+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.110; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+ACN+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.110; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+ACN+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.091; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.091; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.091; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+ACN+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.042; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.024; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+ACN+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LNWMKFPGICKEQH-UHFFFAOYSA-N; [M+ACN+H]+; (1-methyl-2,3-dihydropyridin-6-ylidene)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.991; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+ACN+H]+; N-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.964; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+ACN+H]+; 1-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.964; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.950; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+ACN+H]+; 3-Methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.950; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.950; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+ACN+H]+; 1H-imidazole-1-propylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.734; XNQIOISZPFVUFG-RXMQYKEDSA-N; [M+ACN+H]+; (R)-alpha-methylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.674; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3-[2-(2-cyanoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.544; XNQIOISZPFVUFG-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1H-imidazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.535; FHQDWPCFSJMNCT-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.478; LBGLYAJNIDZGGO-UHFFFAOYSA-N; [M+H]+; 4-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.403; OYBUININCBHVPI-UHFFFAOYSA-N; [M+H]+; 1-(1-methylimidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.220; KDHWOCLBMVSZPG-UHFFFAOYSA-N; [M+ACN+H]+; 3-imidazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.154; PHSPJQZRQAJPPF-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-imidazol-5-yl)-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.776; XIRHPUATWAYWSH-UHFFFAOYSA-N; [M+H]+; 2-[2-[cyanomethyl(methyl)amino]ethyl-methylamino]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.605; UGYXPZQILZRKJJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(5-methyl-1H-imidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.573; ZOMKCDYJHAQMCU-UHFFFAOYSA-N; [M+ACN+H]+; 4-butyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; HLVMFESFZBIMBC-UHFFFAOYSA-N; [M+H]+; 3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.404; DSEMCBZVWDDRJS-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.399; AYEZDNZCTPGJSA-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclopropylmethyl)triazol-4-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.399; AAVVZAZZXUMURZ-UHFFFAOYSA-N; [M+H]+; 2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; VCBYBXAUBOKBSZ-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-4-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.384; CEDXNHGVYPISPG-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.367; QUTNNKVOFOZWEM-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-N,N,6-trimethylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.349; VCZQHTMMBHUSEO-UHFFFAOYSA-N; [M+H]+; (3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; VIUKMNKXXJAZLD-UHFFFAOYSA-N; [M+H]+; 5-piperidin-4-yl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.330; LXSAPEUXYKTICH-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.329; BYVMDDKNSVCZEG-UHFFFAOYSA-N; [M+H]+; 3-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.328; IACZAGXWNRNOBU-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.328; VMPRGXHRBMHXOH-UHFFFAOYSA-N; [M+H]+; 4-(5-methyltriazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.321; CPAGZVLINCPJEH-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.302; PJYAFOPPECXXAT-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.299; DVYSYRXOUIBQJG-UHFFFAOYSA-N; [M+H]+; 4-(5-methyl-1H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; HQNOODJDSFSURF-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-imidazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.295; FJEIRKHYFRMBAB-UHFFFAOYSA-N; [M+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.291; LLWRMGZNTZIBOV-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.291; MEWCPBOFWYJTNM-UHFFFAOYSA-N; [M+H]+; 1-(5-methyl-1H-pyrazol-3-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.290; OAMZBBRGCCAGJL-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.289; IRPFSJQQONMYDX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.284; KAIJJBGBXLAITA-UHFFFAOYSA-N; [M+H]+; 1,3-dimethyl-4,5,6,7-tetrahydropyrazolo[3,4-b]pyridin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.275; HADFJARZQWSNHR-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.275; HWMQIGXDBKSZNN-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-3-yl)pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.269; OIJPPRAITGSIRG-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.266; CJEYOZIHKHZSIM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.264; UZBROTQFSPKCTC-UHFFFAOYSA-N; [M+H]+; 1-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.264; AHGXYHGWKDLIPH-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.263; MBIVPEKQMUQASJ-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.254; ZLGCTFLARAWVND-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; WQYVPLKUHYMUJI-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.244; JTEUFNQZAUZEGI-UHFFFAOYSA-N; [M+H]+; 3-N,3-N,6-N,6-N-tetramethylpyridazine-3,6-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; VAWCWWMADSCPDU-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; RYHAXZZMCHTQKU-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; YLICHTZAMDDIIM-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; VMLRMVKKLVMTPX-UHFFFAOYSA-N; [M+H]+; 3-methyl-3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.222; NOOUZWQNFVDCFF-UHFFFAOYSA-N; [M+H]+; 3-azido-9-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; NHOCIKGCQZOHNI-UHFFFAOYSA-N; [M+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; XDKYTXBAVJELDQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-methyl-1H-imidazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; IPMYPLFTEUENGG-UHFFFAOYSA-N; [M+ACN+H]+; 5-ethyl-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; PGYXLTZSSAXNND-UHFFFAOYSA-N; [M+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; QKVROWZQJVDFSO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-methylimidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; HOSVESHQDSFAST-UHFFFAOYSA-N; [M+H]+; 2-[2-(2-cyanopropan-2-yl)hydrazinyl]-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; HEWBDSWDDPJBLU-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(5-methyl-1H-pyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; BJOZTPFIJGKTJI-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(1-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; SSDGMKHZMNTWLS-UHFFFAOYSA-N; [M+ACN+H]+; 1,3,5-trimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; TYHVEYPFKAWYRG-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(5-methyl-1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; LEHGOSZFUSOULZ-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; CHGIPIYKGPNYKT-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(2-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; CUZNBROTVLFZKQ-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; IHDFTEVCMVTMSP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-imidazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; NKPUYKJNDVFPCP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-pyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; IHOYUFHPGKNPEJ-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethyl-N-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; VMGJEMZVRQAYRA-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; HZOIHLSZMGDITC-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-pyrazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; CWQHAFKSCIBIDU-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; XHOHVIKZCDXJNK-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; UVVVPHSDEZUWCT-UHFFFAOYSA-N; [M+ACN+H]+; 1-methylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; HVJSAASIIATSGA-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; MZHZVOZDOQKYRI-UHFFFAOYSA-N; [M+ACN+H]+; (4-ethyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; RSAZAAWMBSYBFM-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(1-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; YFSZWZHEKIMAJJ-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(1-methylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; JGYXJOBBROGMLL-UHFFFAOYSA-N; [M+ACN+H]+; (1,5-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; JSXVMXHCFBPCLV-UHFFFAOYSA-N; [M+ACN+H]+; 3-pyrazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; YMMVIBHFGRZKPK-UHFFFAOYSA-N; [M+ACN+H]+; (1,5-dimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; VWPUDWHRYBWJRG-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(5-methyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; UUHRZOGUDROUKQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-imidazol-1-yl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; DAOWQCXPMWGSBW-UHFFFAOYSA-N; [M+ACN+H]+; (2,5-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; VERSVOWJFSHXSI-UHFFFAOYSA-N; [M+ACN+H]+; (1,3-dimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; PWGUGJCHHQGZGX-UHFFFAOYSA-N; [M+ACN+H]+; 2-(5-methylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; MIAQYVFWXDEYAK-UHFFFAOYSA-N; [M+ACN+H]+; (1-ethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; VVIZVEAXGCWHOM-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; YZCXLAHTHBVYGB-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1-(3-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; TVKAZNBVXZKTAV-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-2-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; VBRQKQJNZFDLDO-UHFFFAOYSA-N; [M+ACN+H]+; (2-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; SPHPWNVHFXFYGT-UHFFFAOYSA-N; [M+ACN+H]+; 3-(aminomethyl)pyrrolidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; NCMDCWBSYIDNHM-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-methylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.043; UGBXFYZRZQPHFK-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; LLUVLTBWVXCDQN-UHFFFAOYSA-N; [M+ACN+H]+; (1-ethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; QBUQWOXNOUFIGB-UHFFFAOYSA-N; [M+ACN+H]+; (3-ethyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; AXACLKOUNGBFMU-UHFFFAOYSA-N; [M+ACN+H]+; (1,4-dimethylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; XCKQBMQJPNDJLD-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methylimidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; HUIGZWUQSQWMLX-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-aminopyrrolidin-3-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; JMVGTUJLDTZQFC-UHFFFAOYSA-N; [M+ACN+H]+; (3-ethylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; ZKVYCQSCJORSLS-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-imidazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; YDCBPRUBLDZYBI-UHFFFAOYSA-N; [M+ACN+H]+; (2-ethyl-1H-imidazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; YGAHXOAPDMHPMD-UHFFFAOYSA-N; [M+ACN+H]+; (2,3-dimethylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; XAKAVKFLXVMKJT-UHFFFAOYSA-N; [M+ACN+H]+; (1-ethylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; LDDGBHZRCXCJMR-UHFFFAOYSA-N; [M+ACN+H]+; (5-ethyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; ACMQNDYVVBAFQQ-UHFFFAOYSA-N; [M+ACN+H]+; 3-aminopiperidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -55.278; XGYKKVTZDQDYJQ; [M+C4H6N2+H]+; 4-aminobutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.135; VXAOLDZFARINGE; [M+C4H6N2+H]+; (Ethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.579; CSZGEDPWASKNHR; [M+C4H6N2+H]+; 1,4-Diamino-2-butyne
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.954; RHRVANRKEISTIR; [M+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.508; UNIJBMUBHBAUET; [M+C4H6N2+H]+; (2-Cyanoethyl)methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.165; PLXBWEPPAAQASG; [M+C4H6N2+H]+; Dimethylcyanocacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.483; GDIMNXJSMJSDSB; [M+C4H6N2+H]+; 2-Cyanopropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.231; IOLQWFQLCNMKAZ; [M+C4H6N2+H]+; 1,2,3,6-tetrahydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.889; XIRHPUATWAYWSH; [M+H]+; (N,N''-Dimethylethylenedinitrilo)diacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.879; JQULXIOYDDCNGR; [M+C4H6N2+H]+; 2-Cyanoisopropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.159; AYNNMBYJCNKVIJ; [M+C4H6N2+H]+; Acetaldazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.968; MTKGPLGETVCLCF; [M+C4H6N2+H]+; 2-(Methylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.093; VWSLLSXLURJCDF; [M+C4H6N2+H]+; Lysidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.750; VBXZSFNZVNDOPB; [M+C4H6N2+H]+; 1,3-Diazacyclohexene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.421; PGYXLTZSSAXNND; [M+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.645; ZLGCTFLARAWVND; [M+H]+; 4-(1H-1,2,4-triazol-1-ylmethyl)piperidine dihydrochloride
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.664; LLWRMGZNTZIBOV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.350; HOSVESHQDSFAST; [M+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.273; NHOCIKGCQZOHNI; [M+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.994; VIUKMNKXXJAZLD; [M+H]+; 3-piperidin-4-yl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.278; LXSAPEUXYKTICH; [M+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -300.092; JTEUFNQZAUZEGI; [M+H]+; 3,6-Bis(dimethylamino)pyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.731; DGCMIDYTTCDSBB; [M+H]+; 2-N,3-N,4-N-trimethylpyridine-2,3,4-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.452; RHRVANRKEISTIR; [M+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.451; XGYKKVTZDQDYJQ; [M+C4H6N2+H]+; 4-aminobutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.829; CSZGEDPWASKNHR; [M+C4H6N2+H]+; 1,4-Diamino-2-butyne
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.824; OTPDWCMLUKMQNO; [M+C4H6N2+H]+; 1,2,2,3,4,4-Hexadeuteriopyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.013; RHRVANRKEISTIR; [M+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.001; PLXBWEPPAAQASG; [M+C4H6N2+H]+; 2-(dimethylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.484; UNIJBMUBHBAUET; [M+C4H6N2+H]+; 2-Cyanoethyl(methyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -91.339; OHFXUPDPPRJZES; [M+C4H6N2+H]+; 1,2,5,6-Tetrahydropyrimidin-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.533; VWSLLSXLURJCDF; [M+C4H6N2+H]+; 2-Methyl-1-azonia-3-azacyclopentene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.697; AYNNMBYJCNKVIJ; [M+C4H6N2+H]+; Acetaldehyde ethylidenehydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.342; IOLQWFQLCNMKAZ; [M+C4H6N2+H]+; 1,2,3,6-Tetrahydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -97.014; VXAOLDZFARINGE; [M+C4H6N2+H]+; Acetonitrile, (ethylamino)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.312; GDIMNXJSMJSDSB; [M+C4H6N2+H]+; 3-Amino-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.462; VCZQHTMMBHUSEO; [M+H]+; [(6S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.789; XIRHPUATWAYWSH; [M+H]+; N,N'-Dicyanomethyl-N,N'-dimethylethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.187; MBIVPEKQMUQASJ; [M+H]+; (2R)-2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.328; HOSVESHQDSFAST; [M+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.175; PGYXLTZSSAXNND; [M+H]+; 1-(2-Pyrrolidinylethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.622; IACZAGXWNRNOBU; [M+H]+; 1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -172.245; LLWRMGZNTZIBOV; [M+H]+; 2-(1-methyl-1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.934; ZLGCTFLARAWVND; [M+H]+; 4-(1H-1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.572; CEDXNHGVYPISPG; [M+H]+; 1-(1-methyl-1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.365; CSZGEDPWASKNHR; [M+C4H6N2+H]+; 1,4-Diamino-2-butyne
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.361; RHRVANRKEISTIR; [M+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: CONFIDENCE Level 5: Exact mass of interest 167.129049; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 30.162
MS$FOCUSED_ION: PRECURSOR_M/Z 167.129049
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-0900000000-dd14cff5de78da9c3d58
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  97.0760742 120.2936 ? 97.076419 0.7520 15.09 0.8187 13
  124.0869540 33.5226 ? 124.087009 1.0154 6.75 0.2182 11
  138.1026537 34.6807 ? 138.102559 1.7596 7.39 0.7692 13
  139.0866968 28.1764 ? 139.086602 1.8334 6.37 0.4056 12
  167.0814485 61.8757 ? 167.081335 1.2389 17.81 -0.5934 13
  167.1292009 999.0000 ? 167.129088 0.2274 0.00 1.0000 13
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  97.076074 120.29 120
  124.086954 33.52 33
  138.102654 34.68 34
  139.086697 28.18 28
  167.081449 61.88 61
  167.129201 999.00 999
//
